A randomised control trial of high dose oral vitamin D in type 2 diabetes

Completed

• Conditions: Diabetes; Metabolic function; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12611001023943
• Lead Sponsor: Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

diabetes diagnosed in the preceding 12 months, age 30- 60, not on insulin treatment, serum vitamin 25-D3 28-85nmol/L glycated hemoglobin (HbA1c) < 8%.

Exclusion Criteria

insulin treatment, liver impairment, renal impairment (eGFR <50ml/min), hyperparathyroidism, family or personal history of renal calculi, history of recurrent falls, use of a gait aid, past history of a fragility fracture, personal or family history of osteoporosis and current treatment with oral prednisolone, methotrexate or other immunosuppressive drugs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified